Concepedia

M. Paola Castaldi

MP

Statistics

Publications

16

Citations

1.1K

H-Index

13

Active since

2005

Affiliations

AstraZeneca (United States)(Current)

Imperial College London

AstraZeneca (Sweden)

AstraZeneca (United Kingdom)

University of New Hampshire

M. Paola Castaldi is an author at AstraZeneca (United States) specializing in molecular biology, natural sciences, and engineering.

ORCID

Top concepts

Publications per year

2005–2023

16

Publications

16

EED-Targeted PROTACs Degrade EED, EZH2, and SUZ12 in the PRC2 Complex

Jessie Hao-Ru Hsu, Timothy Rasmusson, James Robinson et al. · Cell chemical biology · 2019 · 192 citations · Full text

, ,

Conformational inhibition of the hepatitis C virus internal ribosome entry site RNA

Jerod Parsons, M. Paola Castaldi, Sanjay Dutta et al. · Nature Chemical Biology · 2009 · 158 citations · Full text

, , +8

Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6

William McCoull, Tony Cheung, Erica Anderson et al. · ACS Chemical Biology · 2018 · 133 citations · Full text

, , +14

Dependence on the Pyrimidine Biosynthetic Enzyme DHODH Is a Synthetic Lethal Vulnerability in Mutant KRAS-Driven Cancers

Malvika Koundinya, Judith Sudhalter, Albane Courjaud et al. · Cell chemical biology · 2018 · 118 citations

, , +5

<i>C</i><sub>3</sub> Symmetry: Molecular Design Inspired by Nature

Susan E. Gibson, M. Paola Castaldi · Angewandte Chemie International Edition · 2006 · 99 citations

, , +13

1–5 of 16